Dermavant Sciences

Recent Finacing

Debt

Recent Raise

$200M

Dermavant Sciences is a clinical-stage biopharmaceutical company developing immuno-dermatology therapeutics, including tapinarof, an AHR-modulating topical cream for psoriasis and atopic dermatitis, with a broader dermatology pipeline.

Founded 2016

California, United States

251-500

Private

dermavant.com

Highlights

Focus Areas

Biotechnology

Health Care

Medical

Recent Investors

B

Financials

$200M

Total Raised

1

Funding round

3

Investors

Team

Upgrade to view the team

See the team members at Dermavant Sciences.